Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.38 USD | +6.73% | +8.68% | +73.72% |
05-28 | Chardan Research Starts iBio With Buy Rating, $5 Price Target | MT |
05-13 | IBio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
+73.72% | 20.52M | |
+40.73% | 739B | |
+31.27% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.55% | 240B | |
+9.17% | 210B | |
-5.19% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- IBIO Stock
- News iBio, Inc.
- Transcript : iBio, Inc. Presents at Cantor Global Healthcare 2021 Conference, Sep-27-2021 10